PrismRA (Scipher Medicine)

This report evaluates the analytical validity, clinical validity, and clinical utility of the PrismRA test. According to the laboratory, the PrismRA molecular signature test identifies which patients with rheumatoid arthritis (RA) are unlikely to respond to tumor...

FDA Safety Alert: Noninvasive Prenatal Screening Tests

The U.S. Food and Drug Administration (FDA) is warning patients and healthcare providers about the risks of false results with genetic noninvasive prenatal screening tests.Noninvasive prenatal screening (NIPS) tests analyze small fragments of fetal DNA, called...